TMO
Thermo Fisher Scientific IncNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$182.14B
P/E Ratio
27.62
EPS
$17.75
Beta
0.97
52W High
$643.35
52W Low
$384.44
50-Day MA
$545.40
200-Day MA
$514.90
Dividend Yield
0.36%
Profit Margin
15.00%
Forward P/E
19.16
PEG Ratio
1.76
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Fundamentals
| Revenue (TTM) | $44.56B |
| Gross Profit (TTM) | $18.30B |
| EBITDA | $11.14B |
| Operating Margin | 21.20% |
| Return on Equity | 13.00% |
| Return on Assets | 5.03% |
| Revenue/Share (TTM) | $118.19 |
| Book Value | $141.96 |
| Price-to-Book | 3.30 |
| Price-to-Sales (TTM) | 4.09 |
| EV/Revenue | 4.612 |
| EV/EBITDA | 17.86 |
| Quarterly Earnings Growth (YoY) | 9.30% |
| Quarterly Revenue Growth (YoY) | 7.20% |
| Shares Outstanding | $371.48M |
| Float | $370.55M |
| % Insiders | 0.17% |
| % Institutions | 95.54% |
Historical Volatility
HV 10-Day
31.93%
HV 20-Day
28.84%
HV 30-Day
27.55%
HV 60-Day
27.39%
HV Rank
48.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($663.96 target)
5
Strong Buy18
Buy4
HoldData last updated: 3/25/2026